LBBW Discount Zert KGX 28.06.2024/ DE000LB4GMX9 /
19/06/2024 17:15:09 | Diferencia+0.130 | Bid17:29:01 | Ask17:29:01 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
39.950EUR | +0.33% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
KION GROUP AG | - EUR | 28/06/2024 | Call |
GlobeNewswire
2:51
isandisofx.com Celebrates Major Milestones at 2023 Annual Summary Meeting in Cape Town
GlobeNewswire
2:48
LAKESIDE HOLDING LIMITED ANNOUNCES PRICING OF $6.75 MILLION INITIAL PUBLIC OFFERING
GlobeNewswire
2:22
CFIUS Approval Obtained for the Planned Merger of North American Stainless, Inc. and Haynes Internat...
GlobeNewswire
2:00
ROSEN, THE FIRST FILING FIRM, Encourages FutureFuel Corp. Investors to Secure Counsel Before Importa...
GlobeNewswire
1:51
ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
1:39
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
1:31
PATH INVESTOR ALERT: Edelson Lechtzin LLP Urges UiPath, Inc. (NYSE: PATH) Shareholders to Consult Le...
GlobeNewswire
1:30
ROSEN, A LEADING LAW FIRM, Encourages Charge Enterprises, Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
1:17
TMCF President and CEO Dr. Harry L. Williams has released the following statement on the FY25 House ...
GlobeNewswire
1:15
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fastly, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
1:10
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
1:00
Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA P...
GlobeNewswire
0:30
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página